Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fernanda O Carlos"'
Autor:
Fernanda O Carlos, A.H. Cavalcanti, Christian N. Roderjan, Arthur Fernandes Cortez, Elizabeth S. Muxfeldt, Bernardo Chedier, Bruno Dussoni Moreira Dos Santos
Publikováno v:
Journal of Human Hypertension. 35:709-717
Refractory hypertension (RfHT) is an extreme phenotype of resistant hypertension (RHT) and is considered uncontrolled blood pressure (BP) despite the use of five or more antihypertensives. The objective of this study was to characterize the prevalenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f816c09c64bab98b9f39c9aa05458ed
https://doi.org/10.1038/s41371-020-00406-2
https://doi.org/10.1038/s41371-020-00406-2
Autor:
Bianca B Viegas, Fernanda O Carlos, Nathalie C. Leite, Cristiane A. Villela-Nogueira, Gil F. Salles, Claudia R.L. Cardoso
Publikováno v:
Diabetes, Obesity and Metabolism. 21:1266-1270
The aim was to assess, in a randomized, double-blinded, placebo-controlled trial, the efficacy of diacerein, an anti-inflammatory drug, in improving liver fibrosis and steatosis in patients with type 2 diabetes and non-alcoholic fatty liver disease (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0f7359b0f437878b717be0a13605de8
https://doi.org/10.1111/dom.13643
https://doi.org/10.1111/dom.13643
Autor:
Claudia R.L. Cardoso, Fernanda O Carlos, Nathalie C. Leite, Bianca B Viegas, Gil F. Salles, Andréia A Loureiro
Publikováno v:
Diabetes care. 40(10)
OBJECTIVE To assess, in a randomized, double-blind, and placebo-controlled trial, the efficacy and safety of diacerein, an immune modulator anti-inflammatory drug, in improving glycemic control of patients with type 2 diabetes. RESEARCH DESIGN AND ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb958aa80f2e4482f09c99fb195ba84
https://pubmed.ncbi.nlm.nih.gov/28818994
https://pubmed.ncbi.nlm.nih.gov/28818994
Publikováno v:
American journal of hypertension. 28(2)
BACKGROUND Ambulatory blood pressure (BP) monitoring (ABPM) is a cornerstone in resistant hypertension (RHT) management. However, it has higher cost and lower patients' acceptance than home BP monitoring (HBPM). Our objective was to evaluate HBPM use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6f684db468519a4a11f6fff028c59dd
https://pubmed.ncbi.nlm.nih.gov/25143267
https://pubmed.ncbi.nlm.nih.gov/25143267